His main research concerns Internal medicine, Bipolar disorder, Psychiatry, Endocrinology and Depression. Michael Bauer works mostly in the field of Internal medicine, limiting it down to topics relating to Placebo and, in certain cases, Quetiapine. Michael Bauer has researched Bipolar disorder in several fields, including Genetics, Schizophrenia, Genome-wide association study and Clinical psychology, Mood.
His Schizophrenia research is multidisciplinary, incorporating perspectives in Psychosis and Neuroscience. His work on Major depressive disorder and Antidepressant as part of general Psychiatry research is often related to Task force, thus linking different fields of science. His Major depressive disorder research is multidisciplinary, incorporating elements of Biological psychiatry, Evidence-based medicine, Electroconvulsive therapy and Genetic heterogeneity.
Internal medicine, Psychiatry, Bipolar disorder, Depression and Endocrinology are his primary areas of study. His Internal medicine research is mostly focused on the topic Lithium. His work in the fields of Psychiatry, such as Major depressive disorder and Antidepressant, intersects with other areas such as In patient.
His studies deal with areas such as Genome-wide association study and Clinical psychology, Mood as well as Bipolar disorder. His works in Hormone and Thyroid are all subjects of inquiry into Endocrinology. His Quetiapine study frequently draws connections between adjacent fields such as Quetiapine Fumarate.
Michael Bauer spends much of his time researching Bipolar disorder, Internal medicine, Sepsis, Psychiatry and Depression. Michael Bauer combines subjects such as Genetics, Schizophrenia, Lithium, Genome-wide association study and Clinical psychology with his study of Bipolar disorder. Michael Bauer interconnects Gastroenterology, Endocrinology and Cardiology in the investigation of issues within Internal medicine.
The various areas that Michael Bauer examines in his Sepsis study include Immunosuppression, Immune system and Intensive care medicine. Particularly relevant to Mental illness is his body of work in Psychiatry. Major depressive disorder and Mania are among the areas of Depression where Michael Bauer concentrates his study.
The scientist’s investigation covers issues in Bipolar disorder, Internal medicine, Sepsis, Intensive care medicine and Genome-wide association study. The concepts of his Bipolar disorder study are interwoven with issues in Schizophrenia and Gene. In his research, Fatty liver is intimately related to Endocrinology, which falls under the overarching field of Internal medicine.
He is interested in Organ dysfunction, which is a field of Sepsis. As a part of the same scientific family, he mostly works in the field of Intensive care medicine, focusing on Lithium and, on occasion, Tolerability and Lithium carbonate. His research in Genome-wide association study intersects with topics in Genetic heterogeneity and Comorbidity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer;Clifford S. Deutschman;Christopher Warren Seymour;Manu Shankar-Hari.
JAMA (2016)
IDENTIFICATION OF TISSUE TRANSGLUTAMINASE AS THE AUTOANTIGEN OF CELIAC DISEASE
Walburga Dieterich;Tobias Ehnis;Michael Bauer;Peter Donner.
Nature Medicine (1997)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
Pamela Sklar;Pamela Sklar;Stephan Ripke;Stephan Ripke;Laura J. Scott;Ole A. Andreassen.
Nature Genetics (2011)
Mapping copy number variation by population-scale genome sequencing
Ryan E. Mills;Klaudia Walter;Chip Stewart;Robert E. Handsaker.
(2011)
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
Kirchheiner J;Nickchen K;Bauer M;Wong Ml.
Molecular Psychiatry (2004)
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)
Partially sulfonated poly(arylene ether sulfone) : a versatile proton conducting membrane material for modern energy conversion technologies
R. Nolte;K. Ledjeff;M. Bauer;R. Mülhaupt.
Journal of Membrane Science (1993)
Analysis of shared heritability in common disorders of the brain
Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters.
Science (2018)
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Konrad Reinhart;Michael Bauer;Niels C. Riedemann;Christiane S. Hartog.
Clinical Microbiology Reviews (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Dalhousie University
University of Toronto
Goethe University Frankfurt
University of Barcelona
University of Basel
University of Gothenburg
University of New South Wales
University Hospital of Basel
Oslo University Hospital
Ludwig-Maximilians-Universität München
Aristotle University of Thessaloniki
Northeast Normal University
Stony Brook University
Okayama University
Kunming University of Science and Technology
Qingdao University
Beijing University of Chemical Technology
Okayama University
European Bioinformatics Institute
University of Maine
University of Strasbourg
Centers for Disease Control and Prevention
University of Southern California
Keio University
University at Buffalo, State University of New York
Sorbonne University